Navigation Links
Cantel Medical's Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens' Water Technologies Business Unit
Date:3/25/2013

LITTLE FALLS, N.J., March 25, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), through its Mar Cor Purification subsidiary, has continued the expansion of its water purification and filtration unit with the purchase of the hemodialysis water business from Siemens' Water Technologies business unit. With approximately 600 dialysis customers in the United States and Canada and 2012 revenue of approximately $9 million, this acquisition significantly expands Mar Cor Purification's North American footprint. The acquisition is expected to be slightly accretive to Cantel Medical's earnings per share in fiscal year 2013 and beyond.

Curtis Weitnauer , President and CEO of Mar Cor Purification, stated, "The acquisition of the Siemens hemodialysis water customer base enables Mar Cor to realize increased efficiencies from our existing field service operations while also expanding our footprint into new geographies.  With this geographic expansion, Mar Cor will further improve its ability to service its large national customers.  We look forward to continuing to provide our unique dialysis products and services to our new and existing customers."

Cantel Medical's President and CEO, Andrew Krakauer , added, "This acquisition strengthens our position as a leading provider of water purification products and services to the dialysis industry.  Our advanced heat-based disinfection water technology coupled with our nationwide service footprint makes Mar Cor the best choice for infection prevention and control to our dialysis customers.   We remain confident that our water purification and filtration segment will continue to demonstrate industry leading performance."

About Mar Cor Purification, Inc.

A subs
'/>"/>

SOURCE Cantel Medical Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cantel Medical Reports EPS of $0.38 vs. $0.27 on 9% Sales Increase for Second Quarter Ended January 31, 2013
2. Cantel Medical Reports EPS of $0.35 vs. $0.23 for First Quarter Ended October 31, 2012
3. Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer
4. Cantel Medical Corp. To Present At The CL King 10th Annual Best Ideas Conference
5. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
6. IQAirs New Edition Redefines High-Performance Air Purification
7. Takeda Launches New Subsidiary in Ecuador
8. Generex Touts Pipeline Potential of Antigen Express Subsidiary
9. Novation Holdings Announces Sale of Subsidiary
10. Golden Meditech Holdings Limited Announces Updates on Medical Devices Subsidiary Latest Development
11. China Biologics Guizhou Taibang Subsidiary Donates Lifesaving Plasma Products for the Injured in the Yunnan Earthquake
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)... , March 4, 2015 UPM Pharmaceuticals, a ... agreement with Sprout Pharmaceuticals to manufacture Flibanserin 100 mg ... to be the first drug approved to treat hypoactive ... female sexual dysfunction. The tablets will be ... Bristol, Tennessee . Dr. ...
(Date:3/4/2015)... March 4, 2015   Mayo Clinic and ... develop the next generation of wearable biosensors designed to ... that this technology will be game-changer. These patch biosensors ... James Levine, M.D., Ph.D. , a Mayo Clinic ... inexpensive, and can be integrated into the care people ...
Breaking Medicine Technology:XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is honored ... the company as Chief Technology Officer. Mr. Dvorak will ... company, including customer-centric strategies and initiatives, and promoting continuous ... as a technology executive and visionary. Prior to joining ... including oversight of enterprise data management, analytic software development, ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... March 04, 2015 The Conrad N. ... a total of $6.9 million, which will help 151,000 ... and Burkina Faso. , The programs cover three years ... will focus on fixing water points in disrepair, addressing ... local people to maintain water points and ensuring safe ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nike Swim ... and staff whose mission is to stimulate a love ... “Nike Swim Camps provide campers the opportunity to train ... nation,” says Paul Merrion, Vice President of US Sports ... enabling each swimmer to build confidence and improve their ...
(Date:3/4/2015)... Nitrosigine®, a patented complex of bonded arginine ... products, is hosting the Nitrosigine Pump Challenge at the ... at The Arnold Sports Festival in Columbus, Ohio. The ... 8, 2015. , Nitrosigine is a patented ingredient ... notification status; now affirmed as GRAS.^ It has been ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3
... and Accelerates Physician TrainingGREAT BARRINGTON, Mass., March 17 ... surgical training models, is improving how ENT physicians ... Trainer. This innovative technology was recently designed ... on their new FinESS(TM) Sinus Treatment, a less-invasive ...
... 17 Innophos Holdings, Inc. (Nasdaq: ... declared a dividend of $0.17 per share of common stock. ... stockholders of record as of the close of business on ... , Innophos Holdings, Inc., the parent company of Innophos, Inc. ...
... the past few years, a number of anti-cancer drugs ... key molecules of tumor cells. Among these is an ... that is found in large amounts on the surface ... molecule, called epidermal growth factor receptor, or EGF-R for ...
... for Drug Evaluation and Research (CDER), industry, and academia will convene ... (April 26-29; Arlington, VA) to discuss statistical methodologies and quantitative ... , ... Horsham, PA (Vocus) March 17, 2009 -- ...
... John Hancock Life Insurance Company led the industry ... to recent industry year-end surveys of LTC insurers.* In ... across all of its LTC insurance businesses, giving the ... marks John Hancock,s second year in a row as ...
... What can you buy with a dollar anymore? ... and treatment for those who cannot afford to battle breast ... Brandon Mendelson and the 1 in 8 Foundation are challenging ... $1 and provide care and complete support for women and ...
Cached Medicine News:Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 2Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 3Health News:Innophos Holdings, Inc. Declares Quarterly Dividend 2Health News:Lung cancer: Molecular scissors determine therapy effectiveness 2Health News:Drug Information Association (DIA)and Food and Drug Administration (FDA) to Host 3rd Annual Statistics Forum 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 3Health News:$1 Can Make The Difference 2
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... VACUETTE Blood Collection Needles are preominantly used ... for single-use. The colour of the needle ... individual needle gauges. For example, yellow symbolises ... green 21 G (0.80 mm) and black ...
ScanGel® Centrifuge...
BIOVUE cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack....
Medicine Products: